How big is the Sterile Injectable Contract Manufacturing Market?

The Sterile Injectable Contract Manufacturing Market size is expected to reach USD 14.44 billion in 2024 and grow at a CAGR of 12% to reach USD 28.5 billion by 2029. Read More

What is the current Sterile Injectable Contract Manufacturing Market size?

In 2024, the Sterile Injectable Contract Manufacturing Market size is expected to reach USD 14.44 billion. Read More

Who are the key players in Sterile Injectable Contract Manufacturing Market?

Baxter, Catalent, Inc, Vetter Pharma, Recipharm AB and Aenova Group are the major companies operating in the Sterile Injectable Contract Manufacturing Market. Read More

Which is the fastest growing region in Sterile Injectable Contract Manufacturing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Sterile Injectable Contract Manufacturing Market?

In 2024, the North America accounts for the largest market share in Sterile Injectable Contract Manufacturing Market. Read More

What years does this Sterile Injectable Contract Manufacturing Market cover, and what was the market size in 2023?

In 2023, the Sterile Injectable Contract Manufacturing Market size was estimated at USD 12.71 billion. The report covers the Sterile Injectable Contract Manufacturing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Sterile Injectable Contract Manufacturing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Sterile Injectable Contract ManufacturingCompanies

This report lists the top Sterile Injectable Contract Manufacturing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Sterile Injectable Contract Manufacturing industry.